A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria
Background. Dihydroartemisinin-piperaquine (DP) is a fixed-combination antimalarial drug increasingly deployed in Southeast Asia. The current regimen involves 4 doses given over 3 days. Simplification of the dose regimen should facilitate treatment adherence and thereby increase effectiveness. Metho...
Saved in:
Main Authors: | Elizabeth A. Ashley, Rose McGready, Robert Hutagalung, Lucy Phaiphun, Thra Slight, Stephane Proux, Kyaw Lay Thwai, Marion Barends, Sornchai Looareesuwan, Nicholas J. White, François Nosten |
---|---|
Other Authors: | Shoklo Malaria Research Unit |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/16853 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Randomized, controlled dose-optimization studies of dihydroartemisinin- piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand
by: Elizabeth A. Ashley, et al.
Published: (2018) -
Short report: Dihydroartemisinin - Piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: A preliminary report
by: Marcus J. Rijken, et al.
Published: (2018) -
Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria
by: Joel Tarning, et al.
Published: (2018) -
Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria
by: Marcus J. Rijken, et al.
Published: (2018) -
Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
by: Elizabeth A. Ashley, et al.
Published: (2018)